In summary, our data provide new insight into heparanase mechanism of action in cancer and reveal the potential of anti-heparanase therapy to enhance response to chemotherapy and to prevent tumor relapse, thus improving patient outcome. The gene discussed is HPSE; the disease is neoplasm.